Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors - Grossberg_2013_CNS.Drugs_27_469 |
Author(s) : Grossberg GT , Manes F , Allegri RF , Gutierrez-Robledo LM , Gloger S , Xie L , Jia XD , Pejovic V , Miller ML , Perhach JL , Graham SM |
Ref : CNS Drugs , 27 :469 , 2013 |
Abstract : Grossberg_2013_CNS.Drugs_27_469 |
ESTHER : Grossberg_2013_CNS.Drugs_27_469 |
PubMedSearch : Grossberg_2013_CNS.Drugs_27_469 |
PubMedID: 23733403 |